The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

Danielle M Dunlea, Laura T Fee, Thomas McEnery, Noel G McElvaney, Emer P Reeves Irish Centre for Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland Abstract: Alpha-1 antitrypsin (AAT) is the most abundant serine protease inhibitor c...

Full description

Bibliographic Details
Main Authors:	Dunlea DM, Fee LT, McEnery T, McElvaney NG, Reeves EP
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-03-01
Series:	Journal of Inflammation Research
Subjects:	Neutrophils alpha-1 antitrypsin deficiency alpha-1 antitrypsin augmentation inflammation airways disease
Online Access:	https://www.dovepress.com/the-impact-of-alpha-1-antitrypsin-augmentation-therapy-on-neutrophil-d-peer-reviewed-article-JIR

Similar Items

C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency
by: Laura T. Fee, et al.
Published: (2021-12-01)

Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals
by: Padraig Hawkins, et al.
Published: (2021-08-01)

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma
by: I. Blanco, et al.
Published: (2016-01-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
by: Emanuel Buck, et al.
Published: (2022-01-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
by: Iris G. M. Schouten, et al.
Published: (2021-07-01)

A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
by: Michael E. O’Brien, et al.
Published: (2022-02-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential
by: Paulo Henrique Feitosa
Published: (2023-07-01)

SepA Enhances Shigella Invasion of Epithelial Cells by Degrading Alpha-1 Antitrypsin and Producing a Neutrophil Chemoattractant
by: Mario Meza-Segura, et al.
Published: (2021-12-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
by: Aleksandra Topic, et al.
Published: (2009-01-01)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
by: Herth FJF, et al.
Published: (2021-11-01)

Assessing Patients with Alpha-1 Antitrypsin Deficiency for Corneal Refractive Surgery: A Review and Clinical Experience
by: Majid Moshirfar, et al.
Published: (2022-07-01)

Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
by: I. Suárez-Lorenzo, et al.
Published: (2018-11-01)

Plasma Neutrophil Elastase and its Endogenous Inhibitors as Differential Inflammatory Markers for Dengue and Pneumonia
by: Mamatha Kunder, et al.
Published: (2018-12-01)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
by: Marc Miravitlles, et al.
Published: (2022-12-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.

Effect of alpha-1antitrypsin,adiponectine,leptein in obesity
by: Halla G. Mahmood
Published: (2014-01-01)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
by: Rodrigo Russo, et al.

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

The Study of Alterations of alpha – 1 – Antitrypsin (1-AT) in Serum of Hypothyroid Patients
by: Alireza Kheirollah, et al.
Published: (1998-09-01)

Evaluation of Alpha-1 Antitrypsin Level in the Serum of Children With Idiopathic Bronchiectasis
by: Maryam Babaei, et al.
Published: (2021-11-01)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
by: Sabina Janciauskiene, et al.
Published: (2018-04-01)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
by: Franck F. Rahaghi, et al.
Published: (2017-05-01)

Future Perspectives in the Diagnosis and Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency
by: Nélia Abreu, et al.
Published: (2023-02-01)

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
by: Rahaghi FF, et al.
Published: (2020-12-01)

Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
by: José Luis López-Campos, et al.
Published: (2020-08-01)

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
by: Nygren D, et al.
Published: (2022-06-01)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
by: Beiko T, et al.
Published: (2019-07-01)

Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
by: Torres-Durán M, et al.
Published: (2023-08-01)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
by: Marco Mosella, et al.
Published: (2018-01-01)

Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
by: Mohamed Shahat Badawy, et al.
Published: (2013-04-01)